{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:18:48Z","timestamp":1790144328874,"version":"4.0.1"},"reference-count":60,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Inflammatory bowel diseases (IBD), including Crohn\u2019s disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions requiring continuous monitoring. Today, endoscopy is the gold standard for assessing disease activity, with histological evaluation providing additional insights. Studies suggest that persistent histological inflammation, despite endoscopic remission, may be associated with a higher risk of relapse in UC, suggesting its role in treatment decisions. In CD, histological assessment is limited by its patchy nature, transmural inflammation and lack of validated scoring systems. Few retrospective studies with conflicting results have examined the prognostic value of histological remission in CD, and its role in predicting long-term outcomes remains unclear. This narrative review aims to summarize and discuss the available evidence regarding the additional value of histological assessment in IBD management. In UC, the ongoing VERDICT study is expected to provide evidence on the impact of incorporating histological remission as a treatment target compared to a strategy based on clinical and endoscopic activity. Recently published interim results indicate that targeting histological remission does not lead to better clinical\/biochemical disease activity. Thus, while patients achieving histological healing are associated with better outcomes, the question arises whether achieving histological remission is an intrinsic (biological) characteristic of the patient and indicator of an easier to treat patient group or a result of more effective therapy.<\/jats:p>","DOI":"10.3390\/jcm14072485","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:30:59Z","timestamp":1744003859000},"page":"2485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Role of Histology Alongside Clinical and Endoscopic Evaluation in the Management of IBD\u2014A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0900-1966","authenticated-orcid":false,"given":"Dorottya","family":"Angyal","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-4024","authenticated-orcid":false,"given":"Fruzsina","family":"Balogh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"},{"name":"Division of Gastroenterology, Central Hospital of Northern Pest, Military Hospital, 1062 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-1910","authenticated-orcid":false,"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, McGill University, Montreal, QC H3A 0G4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5962-4112","authenticated-orcid":false,"given":"Panu","family":"Wetwittayakhlang","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-2642","authenticated-orcid":false,"given":"Akos","family":"Ilias","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8819-6460","authenticated-orcid":false,"given":"Lorant","family":"Gonczi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3948-6488","authenticated-orcid":false,"given":"Peter L.","family":"Lakatos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"},{"name":"Division of Gastroenterology, McGill University, Montreal, QC H3A 0G4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/gut.35.2.231","article-title":"Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn\u2019s disease. A prospective multicentre study of 121 cases. The Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives","volume":"35","author":"Cellier","year":"1994","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn\u2019s disease in the SONIC trial","volume":"63","author":"Reinisch","year":"2014","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cgh.2013.11.005","article-title":"Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn\u2019s disease","volume":"12","author":"Bouguen","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.dld.2013.07.005","article-title":"Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease","volume":"45","author":"Orlando","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.gastro.2016.09.046","article-title":"Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases","volume":"152","author":"Colombel","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): A multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target","volume":"110","author":"Sandborn","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","article-title":"New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort","volume":"103","author":"Papp","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"Colombel","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"463-e11","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2010.12.028","article-title":"Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis","volume":"9","author":"Ardizzone","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.gie.2017.07.028","article-title":"Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: A systematic review and meta-analysis","volume":"86","author":"Flores","year":"2017","journal-title":"Gastrointest. Endosc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.gastro.2014.08.003","article-title":"Converging goals of treatment of inflammatory bowel disease from clinical trials and practice","volume":"148","author":"Levesque","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.22977","article-title":"Mucosal healing in Crohn\u2019s disease: A systematic review","volume":"19","author":"Kamm","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: A systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: What does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/ibd.21268","article-title":"Mucosal healing as an index of colitis activity: Back to histological healing for future indices","volume":"16","author":"Korelitz","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41575-019-0211-1","article-title":"Evolving therapeutic goals in ulcerative colitis: Towards disease clearance","volume":"17","author":"Danese","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/17474124.2020.1804361","article-title":"Treat to target or \u2018treat to clear\u2019 in inflammatory bowel diseases: One step further?","volume":"14","author":"Roda","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","article-title":"ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology","volume":"14","author":"Magro","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gutjnl-2017-315545","article-title":"Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels","volume":"68","author":"Magro","year":"2019","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1136\/gutjnl-2018-317547","article-title":"Definitions of response and remission for the Robarts Histopathology Index","volume":"68","author":"Pai","year":"2019","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Salleron","year":"2017","journal-title":"Gut"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1053\/j.gastro.2021.02.035","article-title":"An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials","volume":"160","author":"Ma","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vespa, E., D\u2019Amico, F., Sollai, M., Allocca, M., Furfaro, F., Zilli, A., Dal Buono, A., Gabbiadini, R., Danese, S., and Fiorino, G. (2022). Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040939"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/ecco-jcc\/jjac006","article-title":"ECCO Position on Harmonisation of Crohn\u2019s Disease Mucosal Histopathology","volume":"16","author":"Magro","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_31","unstructured":"(2016). Ulcerative Colitis: Clinical Trial Endpoints."},{"key":"ref_32","unstructured":"(2018). Guideline on the Development of New Medicinal Products for the Treatment of Ulcerative Colitis."},{"key":"ref_33","unstructured":"(2022). Ulcerative Colitis: Developing Drugs for Treatment."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/ajg.2016.418","article-title":"Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis","volume":"111","author":"Park","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis","volume":"19","author":"Gupta","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","article-title":"Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis","volume":"159","author":"Yoon","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3904\/kjim.2023.167","article-title":"Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity","volume":"39","author":"Shin","year":"2024","journal-title":"Korean J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MCG.0000000000001681","article-title":"Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission","volume":"57","author":"Wang","year":"2023","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ibd\/izac075","article-title":"Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1","volume":"29","author":"Seong","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"otad059","DOI":"10.1093\/crocol\/otad059","article-title":"Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission","volume":"5","author":"George","year":"2023","journal-title":"Crohn\u2019s Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/ibd\/izab340","article-title":"Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse","volume":"28","author":"Park","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ecco-jcc\/jjaa184","article-title":"Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint","volume":"15","author":"Jangi","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/apt.16147","article-title":"Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission","volume":"52","author":"Narula","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kim, J.E., Kim, M., Kim, M.J., Kim, E.R., Hong, S.H., Chang, D.K., Ha, S.Y., and Kim, Y.H. (2024). Histologic improvement predicts endoscopic remission in patients with ulcerative colitis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-68372-0"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Wei, Z.H., Wu, R.C., Kuo, C.J., Chiu, H.Y., Yeh, P.J., Chen, C.M., Chiu, C.T., Tsou, Y.K., Chang, C.W., and Pan, Y.B. (2024). Impact of completely histological remission on reducing flare-ups in moderate-to-severe, biologics-experienced ulcerative colitis patients with endoscopic remission. J. Formos. Med. Assoc., in press.","DOI":"10.1016\/j.jfma.2024.08.001"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e001218","DOI":"10.1136\/bmjgast-2023-001218","article-title":"Determining the optimal treatment target in patients with ulcerative colitis: Rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial","volume":"11","author":"Jairath","year":"2024","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_47","first-page":"i252","article-title":"DOP094 Improvement in biomarkers in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trial","volume":"19","author":"Jairath","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_48","first-page":"i92","article-title":"DOP007 Change in Histological inflammation in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trial","volume":"19","author":"Jairath","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"i1039","DOI":"10.1093\/ecco-jcc\/jjae190.0676","article-title":"P0502 Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis: 3-year and 5-year follow-up","volume":"19","author":"Abbas","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cgh.2020.04.050","article-title":"Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn\u2019s Disease in Endoscopic Remission","volume":"19","author":"Hu","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.cgh.2019.11.056","article-title":"Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn\u2019s Disease than Endoscopic Healing","volume":"18","author":"Christensen","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MCG.0000000000000507","article-title":"Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn\u2019s Disease in Remission","volume":"51","author":"Brennan","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21925","article-title":"Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation","volume":"18","author":"Baars","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ibd\/izaa301","article-title":"Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission","volume":"27","author":"Yoon","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Reenaers, C., Enea, D., Nachury, M., Laharie, D., Bouhnik, Y., Fumery, M., Gornet, J.M., Amiot, A., Altwegg, R., and de Vos, M. (2024). Impact of histological remission for predicting clinical relapse in Crohn\u2019s disease: A post-hoc analysis of the prospective STORI cohort. J. Crohn\u2019s Colitis, jjae167.","DOI":"10.1093\/ecco-jcc\/jjae167"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: A systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhao, M., Riis, L.B., Lo, B., Attauabi, M., Ovesen, P.D., Wewer, M.D., Larsen, L., Dige, A., Hvas, C.L., and Poulsen, A. (2024). Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics. Inflamm. Bowel Dis., izae287.","DOI":"10.1093\/ibd\/izae287"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"i815","DOI":"10.1093\/ecco-jcc\/jjae190.0521","article-title":"P0347 Correlation between histologic disease activity in the distal and proximal colon in Ulcerative Colitis: A flexible sigmoidoscopy is insufficient to assess histology","volume":"19","author":"Marcus","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Santacroce, G., Zammarchi, I., Nardone, O.M., Capobianco, I., Puga-Tejada, M., Majumder, S., Ghosh, S., and Iacucci, M. (2025). Rediscovering histology\u2014The application of artificial intelligence in inflammatory bowel disease histologic assessment. Ther. Adv. Gastroenterol., 18.","DOI":"10.1177\/17562848251325525"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J. Crohn\u2019s Colitis"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:10:50Z","timestamp":1760029850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/7\/2485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14072485"],"URL":"https:\/\/doi.org\/10.3390\/jcm14072485","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]}}}